Illegal wildlife trade (IWT) is in the global spotlight thanks to its alleged role in triggering the coronavirus pandemic. It is sparking vivid debate among communities of experts not just in conservation, but in business, finance, technology, anti-corruption forces and law.
Illegal wildlife trade (IWT) is in the global spotlight thanks to its alleged role in triggering the coronavirus pandemic. It is sparking vivid debate among communities of experts not just in conservation, but in business, finance, technology, anti-corruption forces and law.
Illegal wildlife trade (IWT) is in the global spotlight thanks to its alleged role in triggering the coronavirus pandemic. It is sparking vivid debate among communities of experts not just in conservation, but in business, finance, technology, anti-corruption forces and law.
The Ethical Principles in Health Care (EPiHC) were developed by the International Finance Corporation (IFC), a member of the World Bank Group, and are managed by an independent Secretariat.
The aim is to provide a “compass” to help healthcare actors deal with the challenges of the healthcare landscape and “help providers make a stronger contribution to the lives of their patients, their staff, the environment, and the communities they serve.” Its scope covers private healthcare providers, payors and investors.
Last updated: 22.06.2020
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.
The mission of the Inter-American Coalition for Business Ethics in the Medical Technology Sector is to realise full implementation of the Bogotá Principles across the Americas. The Bogotá Principles were launched in 2017 to promote high-standard international ethical business practices for all stakeholders in the western hemisphere that operate within or interact with the medical technology sector.
The scope covers:
Last updated: 22.06.2020
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.
The Australian Ethical Health Alliance (AEHA) was formed in April 2019 to oversee implementation of the Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector. This is a consensus of shared values and ethical principles that form the basis of collaboration and interaction among organisations in the Australian healthcare sector. The sector-led initiative has 70+ member organisations representing:
Last updated: 27.04.2021
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.
The Consensus Framework for Ethical Collaboration was established in 2014 as a platform for ethical collaboration between patients’ organisations, healthcare professionals and the pharmaceutical industry. The ultimate aim is to improve the quality of patient care.
It has four overarching principles:
The Consensus Framework is supported by:
Last updated: 09.08.2021
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.
This Business Ethics for APEC SMEs Initiative is a public-private partnership with the aim of strengthening ethical business practices in the medical device and biopharmaceutical sectors. It is overseen by the US Department of Commerce and is supported by member economies of the Asia-Pacific Economic Cooperation forum (APEC).
Last updated: 22.06.2020
This information is gathered from open-source data and in some cases has been provided by initiative facilitators. We cannot guarantee the accuracy or completeness of the information and do not take responsibility for decisions made on the basis of it. Please inform us of any errors by emailing us at the contact details on the main database page.
The recently published Global Mapping of Anti-Corruption Authorities fills a critical gap in information about national anti-corruption authorities (ACAs) around the world. ACAs are key institutions to prevent and combat corruption, but until now centralised data on their mandates, activities and even existence has been lacking.
The global disruption from covid-19 to health and economic systems has magnified risks to preserving business integrity that will have longstanding impact. As a result, the pandemic is drawing significant attention to several of the world’s largest Collective Action initiatives that are reinforcing ethical business conduct in healthcare. The timing and actions of these initiatives could not be more critical in our crisis recovery efforts.